Literature DB >> 11588726

[Behçet's disease with atypical double neurological involvement].

E Durán1, J R Chacón.   

Abstract

INTRODUCTION: Neurological involvement in Behçet s disease (BD) occurs in 10 30% of the cases and is usually central, with the peripheral nervous system being rarely involved. It is also unusual for the disorder to present with neurological features at the onset. CLINICAL CASE: A 51 year old man with an undefined history of brainstem encephalitis and epileptic seizures. He later developed a cerebellar syndrome and relapsing orogenital ulcers, diagnosed as BD with involvement of the central nervous system. At the present time the patient complained of marked deterioration in gait and progressive difficulty with carrying out everyday tasks using his upper limbs. On neurological examination there was paresia of the right VI cranial nerve, hyporeflexia of the left half of his body, left hypo esthesia (slight for touch and discrimination, but marked for proprioception) and dissymmetry of upper and lower left limbs. Complementary investigations showed there to be sensory polyneuropathy of the left arm and leg. Both central and peripheral nervous system alterations improved on steroid treatment.
CONCLUSION: The probable onset of BD with central nervous system alterations and subsequent appearance of peripheral neuropathy are infrequent findings in BD. The relation of both disorders with vasculitis is reinforced by the good response to immunosuppressive treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11588726

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  2 in total

1.  [Myalgia in Neuro-Behçet's disease. Medication side effects or expression of underlying disease].

Authors:  M Krämer; M W Baumgärtel; E Neuen-Jacob; P Berlit
Journal:  Z Rheumatol       Date:  2008-05       Impact factor: 1.372

Review 2.  Behcet's disease with peripheral nervous system involvement successfully treated with golimumab: a case report and review of the literature.

Authors:  Menghui Yao; Congcong Gao; Chunyi Zhang; Xueqi Di; Wenfang Liang; Wenbo Sun; Qianqian Wang; Zhaohui Zheng
Journal:  Rheumatol Int       Date:  2020-07-16       Impact factor: 2.631

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.